Scopus Asset Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-34,860
Closed -$2.63M 380
2021
Q1
$2.63M Sell
34,860
-23,240
-40% -$1.7M 0.03% 289
2020
Q4
$3.82M Sell
58,100
-29,050
-33% -$1.7M 0.06% 248
2020
Q3
$4.7M Buy
87,150
+29,050
+50% +$1.6M 0.09% 189
2020
Q2
$2.79M Buy
+58,100
New +$2.57M 0.08% 177
2020
Q1
Sell
-145,250
Closed -$9.1M 118
2019
Q4
$9.1M Buy
+145,250
New +$8.21M 0.3% 101
2019
Q3
Sell
-116,200
Closed -$5.61M 142
2019
Q2
$5.61M Buy
+116,200
New +$5.59M 0.16% 131

Other funds holding ENOV

Scopus Asset Management's ENOV Position: Q3 2021 in Review

Scopus Asset Management sold out of Enovis (ENOV) in Q3 2021, closing a stake of 55,917 shares — an estimated $4.41M sold.

Scopus Asset Management first reported a position in ENOV in Q1 2014 and held it in 12 quarters. The position peaked at $32.8M in Q4 2019. 272 funds tracked by Wall St. Rank hold ENOV as of Q3 2021.

  • Scopus Asset Management reported no remaining Enovis position as of Q3 2021 after selling out during the quarter.
  • Scopus Asset Management sold 55,917 Enovis shares in Q3 2021, an estimated $4.41M.
  • Scopus Asset Management first reported a position in Enovis in Q1 2014 and held it in 12 quarters.
  • Scopus Asset Management's Enovis position peaked at $32.8M in Q4 2019.
  • 272 funds tracked by Wall St. Rank held Enovis as of Q3 2021.

Based on Scopus Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.